What does Exicure, Inc. do?

Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple…

What is Exicure, Inc.'s P/E and P/B ratio?

Exicure, Inc. has a P/E ratio of -0.9 and a P/B ratio of 7.57.

What is Exicure, Inc.'s debt-to-equity ratio?

Exicure, Inc. has a debt-to-equity ratio of 0.04.

How much does Exicure, Inc. owe compared with what it owns?

Exicure, Inc. owes $0.91 for every $1 it owns (balance sheet Jun 2026), which is high.

Does Exicure, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. Exicure, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 16 Sep 2026). It also has 1 yellow flag (PosiYellow stress signals, 2/10 points): Quarterly report filed late (NT 10-Q).

Where can I read the latest news about Exicure, Inc.?

Recent headlines about Exicure, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Exicure, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Exicure, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

Exicure, Inc.

Q: What is Exicure, Inc.'s Positivity rank?

Exicure, Inc. is ranked #4,595 of 6,774 companies globally and #2,342 of 4,000 in United States on PositoAI, with a Positivity Score of 19,232.

NasdaqCM: XCUR · Healthcare

Positivity Index

#4,595 / 6,774

Global

#2,342 / 4,000

United States

Positivity Score

19,232

Rank→

PosiRed: 1 active red flag (highest severity 6/10) · PosiYellow: 1 yellow flag (2/10 points) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 16 Sep 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

PosiYellow · yellow flag (stress signal)

Quarterly report filed late (NT 10-Q)

The company filed Form NT 10-Q with the SEC on 15 May 2026, notifying investors that its quarterly report would be late. Late filings can point to accounting or business problems, though the reason is sometimes routine.

More details →

Exicure, Inc. — Overview & Financial Snapshot

Exicure, Inc. (NasdaqCM: XCUR) is a Healthcare company, ranked #4,595 of 6,774 companies globally and #2,342 of 4,000 in United States on PositoAI, with a Positivity Score of 19,232. Its market capitalisation is ₹69.82 Cr ($7.40M), P/E ratio is -0.9 and P/B ratio is 7.57. It currently has 1 active red flag (PosiRed) and 1 yellow flag (PosiYellow, 2/10 points) on record.

For financial statements, ratio trends and score history, Go Deep →